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Abstract Despite the classification as known or suspected
human carcinogens, by the International Agency for
Research onCancer, the antineoplastic drugs are extensively
used in cancer treatment due to their specificity and efficacy.
As human carcinogens, these drugs represent a serious
threat to the healthcareworkers involved in their preparation
and administration. This work aims to contribute to better
characterize the occupational exposure of healthcare profes-
sionals to antineoplastic drugs, by assessing workplace
surfaces contamination of pharmacy and administration
units of two Portuguese hospitals. Surface contamination
was assessed by the determination of cyclophosphamide, 5-
fluorouracil, and paclitaxel. These three drugs were used as
surrogate markers for surfaces contamination by cytotoxic
drugs. Wipe samples were taken and analyzed by HPLC-
DAD. From the total of 327 analyzed samples, in 121
(37%)was possible to detect and quantify at least one drug.
Additionally, 28 samples (8.6 %) indicate contamination by
more than one antineoplastic drug, mainly in the adminis-
tration unit, in both hospitals. Considering the findings in
both hospitals, specific measures should be taken, particu-
larly those related with the promotion of good practices and
safety procedures and also routine monitoring of surfaces
contamination in order to guarantee the appliance of safety
measures.
Keywords Cytotoxic drugs . Surfaces contamination .
Wipe sampling . Occupational exposure assessment
Introduction
Antineoplastic drugs are essential for cancer treatment.
Nevertheless, they can pose a serious threat to the healthcare
workers involved in their preparation and administration
(Shirato 1992; McDevitt et al. 1993; Connor and
McDiarmid 2006; Yoshida et al. 2013), since most of them
are classified by the International Agency for Research on
Cancer as known or suspected human carcinogens (IARC
2012).
The risk associatedwith occupational exposuremost-
ly arises from chronic exposure to these agents. Over the
last 30 years, particularly in Europe and North America,
as awareness increased, numerous safety guidelines
have been developed and published, aiming the protec-
tion of workers health, specifically diseases associated
with these occupational settings. However, and despite
the investment made in personal protective equipment,
biological safety cabinets and workers training, occupa-
tional exposure of health care workers is still being
reported (Fransman et al. 2007; Hedmer et al. 2008;
Connor et al. 2010; Sugiura et al. 2011; Kopp et al.
2013; Miyake et al. 2013).
Recent studies have shown that workplace contami-
nation due to poor work practices is a major cause of
occupational exposure (Connor et al. 2010; Kiffmeyer
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et al. 2013). It may be impossible to eliminate all risk;
however, it is imperious to reduce risk to the lowest level
(Davis et al. 2011).
Exposure to these drugs can occur essentially by three
ways: inhalation of aerosolized drugs; dermal absorption
caused by direct skin contact; and, less frequently, ingestion
due to contaminated hands (Turci et al. 2003). Presently,
due to the evolution of the technical protection resources
available in the workplaces, such as biological safety cabi-
nets (BSC) and hoods, the most common route of exposure
is skin absorption rather than inhalation or ingestion
(Minoia et al. 1998). Recent studies showed also that anti-
neoplastic levels in air samples were not significantly de-
tected, suggesting that inhalationmight have a lower impact
when assessing exposure (Mason et al. 2005; Connor et al.
2010; Huang et al. 2012). Therefore, contact with contam-
inated workplace surfaces without gloves seems to play an
important role in the dermal exposure to antineoplastic
drugs (Hirst et al. 1984; Sessink et al. 1994; Kromhout
et al. 2000; Fransman et al. 2005; Schierl et al. 2009). In
this context, most of the recently published studies give
particular attention to the assessment of surfaces contami-
nation and report a generalized contamination, even in
hospitals with the best equipment and strict safety proce-
dures (Turci et al. 2003; Hedmer et al. 2005; Mason et al.
2005; Brouwers et al. 2007; Hon et al. 2011, 2013; Kopp
et al. 2013). Moreover, since drugs are expected to be
handled during both preparation and administration, it is
important to differentiate pharmacy and patient wards (Hon
et al. 2011; Kopp et al. 2013).
This work aims to contribute to better characterize
the occupational exposure of healthcare professionals to
antineoplastic drugs, by assessing workplace surfaces
contamination of pharmacy and administration units of
two Portuguese hospitals. Additionally, it is intended to
discuss the factors that may be associated with surface
contamination.
Materials and methods
Cyclophosphamide (CP), 5-fluorouracil (5FU), and pac-
litaxel (PTX) were used as surrogate markers for sur-
faces contamination by all cytotoxic drugs.
Selection of sampling surfaces
Before determining workplace contamination, it was
necessary to understand where and how the workers
can be in contact with contaminated surfaces in those
units. Each hospital unit was visited at least in three
separate occasions during the year of 2012. Direct and
passive observations at each site were conducted by
members of the research team to visually identify which
surfaces/objects may be contaminatedwith antineoplastic
drugs. A flowchart (not shown) was developed for each
unit describing the antineoplastic drugs route from the
pharmacy to the patient administration unit, and what
surfaces/objects came into contact with the drug products
and are touch/handled by the health staff.
The selected sampling spots (Tables 1 and 2) were
judged to be the surfaces more potentially contaminated
and, simultaneously, more frequently handled/touched
by the health workers in the course of their routine tasks.
Wipe sampling
The surfaces were sampled in the first 3 months of the
year 2013 in two different days in each hospital. The
days were selected based on the workers classification
as “normal” regarding preparation and administration of
drugs.
Also, during the sampling period, data about which
drugs were handled was collected.
Surface areas of 100 cm2, defined by a stainless frame
with an internal size of 10×10 cmwere wipe-sampled with
gauze moistened with ethyl-acetate as described elsewhere
(Schmaus et al. 2002). The framewas cleaned between each
sample, and a new pair of gloves was used for each wipe
sample. All wipe samples were collected by the same
person to guarantee reliable sampling. In the case of irreg-
ular surfaces such as phones, armrests, and handles, the
wiped area was estimated and the result employed to cal-
culate the contamination.
Table 1 Sampling sites considered relevant in hospital A (n=67)
Sampling sites Unit
Transfer (shelf and door handles) Preparation
Cleanroom (worktops, trays, door handles) Preparation
Anteroom (worktops, trays) Preparation
Storage cabinet (shelf and door handles) Preparation
Worktops (tables) Administration
Administration devices (infusion pumps) Administration
Transfer (shelf and door handles) Administration
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Wipe sample extraction
All wipe samples were extracted as described elsewhere
(Schmaus et al. 2002). The wipes were extracted with
15 mL of acetonitrile/methanol/water (10:25:65) for
20 min at room temperature in a bottleroller homoge-
nizer. Extracts were filtered through a 0.22-μm filter
prior to injection. Blank wipes were extracted according
to the procedure described above and analyzed reveal-
ing no impurities that could interfere with the determi-
nation of the antineoplastic drugs (different retention
times in the chromatogram).
HPLC-DAD separation and quantification
Separation and quantification was performed according
to Larson and colleagues (2002) on a Thermo-
UNICAM Surveyor HPLC-DAD; 100-μL sample loop;
column Hypersil-GOLD 15×5×4.6 with a guard col-
umn; mobile phase of acetonitrile/methanol/water
(19:13:68) at a flow of 0.8 mL min−1. All HPLC grade
solvents were purchased fromVWR. CP, 5FU, and PTX
were purchased from Sigma. For all the drugs, calibra-
tion curves were performed after extraction of spiked
wipes. Each sample was injected in triplicate. Results
are the mean with RSD under 5 %. LOD and LOQwere
defined for each drug (Table 3). Concentrations above
LOQ were considered quantified. The values below
LOQ were considered detected but not quantifiable
and are reported as <LOQ. Values below LOD were
considered non-detected and are reported as ND.
Statistical analysis
Data analysis was performed using SPSS version 22.0.
For comparison of two independent groups, we used the
Mann–WhitneyU test. For comparison of the fraction of
surfaces where contamination had values below LOQ
and a comparison of the fraction of surfaces where
contamination had values above LOQ, between prepa-
ration and administration units in each hospital, we used
the equality of proportions test with two independent
samples.
Ethical considerations
This study was approved by the respective Institutional
Ethic Boards of both hospitals and by Portuguese
Authority for Work Conditions.
Results
Setting
The two hospitals enrolled on the study present very
similar working practices: the preparation is centralized
in one unit controlled by the pharmacist and prepared by
pharmacy technicians; the administration of cytotoxic
drugs is the responsibility of nursing staff.
Main characteristics of both hospitals
In hospital A, between the checking room and the
cleanroom exists a transfer system/pass through hatches,
which allows a separation of drugs for preparation and
admixtures for administration. The preparation unit is
linked to the oncology ward, where the administration
takes place, also through a transfer system. The transport
of cytotoxics for the oncology ward does not occur
before the preparation is finished. After preparation,
the nurses collect it from the transfer in trays.
In hospital B, the preparation unit is centralized in the
pharmacy, and the admixtures are carried in hard-walled
and robust containers to the administration unit.
Both hospitals use class II BSC in a grade B room for
the preparation of cytotoxic drugs, two in hospital A,
and three in hospital B. In the preparation unit, personal
protective equipment for pharmacy technicians includes
overshoes, head covering, goggles, mask P2/P3, sterile
gown, and sterile gloves (two pairs). The pharmacists, in
Table 2 Sampling sites considered relevant in hospital B (n=260)
Sampling sites Unit
Transfer (shelf and door handles) Preparation
Cleanroom (front barrier grille of the BSC,
chairs, worktops, trays, door handles)
Preparation
Anteroom (worktops) Preparation
Storage cabinet (shelf and door handles) Preparation
Checking room (phone, desks and worktops, chairs,
calculators and PC)
Preparation
Worktops (tables and cars) Administration
Administration devices (control panels,
infusion pumps)
Administration
Treatment chairs (armrests) and beds Administration
Personal protection equipment (gloves) Administration
Drug container (packing after preparation
and box for manual transportation)
Administration
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the checking room, wear one pair of gloves as the
nursing staff in administration ward.
Top five drugs prepared in both hospitals include
5FU, CP, and PTX. The mean number of drug
preparations/day is approximately 60, with a team of
five pharmacy technicians, two pharmacists and five
nurses in an 8-h shift.
Cleaning procedures are also similar for both hospi-
tals. Pharmacy technicians are responsible for cleaning
and disinfection of BSC, but the facilities of the prepa-
ration and administration units are cleaned by an
outsourced cleaning service.
From the 327 analysed samples of both hospitals,
121 (37 %) were positive (>LOQ). A sample was
regarded as positive, when at least one of the three
surrogate markers was detected and quantified.
Besides this and although impossible to quantify,
there were more 117 samples (35.8 %) that showed also
the presence (<LOQ) of one or more markers.
Considering hospital A, from the 67 samples, 21
(31.3 %) were positive and 13 of them (19.4 %) pre-
sented contamination with more than one drug. In the
latter, 9 (69.2 %) were sampled in the administration
unit. In hospital B, 100 (38.5 %) out of 260 samples
were positive and 15 (5.8 %) showed contamination
from more than one drug and 13 (86.7 %) of them were
from the administration unit (Table 4).
Drug contamination results (>LOQ) were also com-
pared between preparation and administration units in
each hospital (Mann–Whitney U test). In this case, 5FU
(U=276.0; p=0.001) and PTX (U=344.5; p=0.003)
contaminations were significantly different in both areas
in hospital A. Regarding hospital B, PTX (U=4747.5;
p=0.000) and CP (U=6706; p=0.025) also showed
statistical differences between the two units.
In both hospitals, the administration unit showed
higher values.
In addition and considering the results presented in
Tables 5 and 6, we performed a comparison of the
fraction of surfaces where contamination had values
below LOQ and a comparison of the fraction of surfaces
where contamination had values above LOQ, between
preparation and administration units in each hospital
(equality of proportions test with two independent sam-
ples). The results showed statistically significant differ-
ences between the preparation and the administration
units in hospital B, verifying that the preparation has a
significantly higher fraction of surfaces where contam-
ination had values below LOQ (z=3.191, p=0.001).
Regarding fraction of surfaces where contamination
had values above LOQ, statistically significant differ-
ences were found between the preparation and adminis-
tration units on the 5FU (z=−3.049, p=0.002) and on
the Taxol (z=−2.762, 0=0.006) in the hospital A. In
hospital B, also statistically significant differences were
found on the 5FU (z=−1.410, p=0.032) and on the
Taxol (z=−5.780, p<0.0001). In either case, the fraction
of surfaces where contamination had values above LOQ
is greater in the administration unit.
Surface contamination in hospital A
Considering hospital A (Table 5), in the samples of the
administration areas, 3.7 % samples contaminated with
Table 3 Analytical data
LOD detection limit, LOQ quan-
tification limit
Drug CP 5FU PTX
LOD 0.10 μg/cm2 3.30 ng/cm2 0.167 ng/cm2
LOQ 0.30 μg/cm2 10.00 ng/cm2 0.50 ng/cm2
R2 0.9937 0.9933 0.9978
Peak area 4,236.43+639,570×CP −129,764+127,590×5FU 2,903.38+219,663×PTX
Table 4 Results of surface contamination
Hospitals Samples with contamination Contamination with
more than 1 drug
CP 5FU PTX
A 21/67 (31.3 %) 13/67 (19.4 %) 1/67 (1.5 %) 17/67 (25.4 %) 17/67 (25.4 %)
B 100/260 (38.5 %) 15/260 (5.8 %) 14/260 (5.4 %) 18/260 (6.9 %) 54/260 (27.3 %)
Totals 121/327 (37 %) 28/327 (8.6 %) 15/327 (4.6 %) 35/327 (10.7 %) 71/327 (21.7 %)
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CP (>LOQ) and 11%was detected CP (<LOQ). 8.1 and
44.4 % 5FU-contaminated samples were found in prep-
aration and administration areas. 5FU was detected in
both preparation and administration areas (11.3 and
26.0 %, respectively). PTX-contaminated samples
(11.3 and 85.2 %) were found in preparation and
administration areas. The highest measured value
for CP (2.6 μg/cm2) was obtained in a worktop
that gives support to the drug administration
process.
In the case of 5FU, the highest value (78.8 ng/cm2)
was found in the refrigerator closet where drugs are
stored located in the preparation unit. The surface that
obtained the highest measured value of PTX (19.7 ng/
cm2) was the transfer shelf from the administration unit.
Surface contamination in hospital B
Considering hospital B (Table 6), a 4.1 and 7 % CP
(>LOQ)-contaminated samples were found in prepara-
tion and administration areas. Additionally, was detect-
ed CP in both preparation and administration (4.1 and
16.5 %, respectively). 5FU-contaminated samples (6.9
and 7 %) were found in preparation and administration
areas. Moreover, 5FU was also detected in other sam-
ples from both preparation and administration areas
Table 5 Surface contamination level by each drug in Hospital A (n=67)
Unit Surface Drug
n/n total (%)–range
CP 5FU PTX
Preparation (n=40) Transfer (shelf and door handles) Shelfs
ND 7/7 (100 %)
Door handles
ND 4/4 (100 %)
Shelfs
ND 3/7 (42.9 %)
<LOQ 3/7 (42.9 %)
>LOQ 1/7 (14.3 %)
13.7 ng/cm2
Door handles
ND 4/4 (100 %)
Shelfs
ND 7/7 (100 %)
Door handles
ND 4/4 (100 %)
Cleanroom (worktops, trays, door handles) Worktops
ND 2/2 (100 %)
Trays
ND 7/7 (100 %)
Door handles
ND 2/2 (100 %)
Worktops
ND 2/2 (100 %)
Trays
ND 7/7 (100 %)
Door handles
ND 2/2 (100 %)
Worktops
ND 2/2 (100 %)
Trays
ND 7/7 (100 %)
Door handles
ND 2/2 (100 %)
Anteroom (worktops, trays) Worktops
ND 4/4 (100 %)
Trays
ND 2/2 (100 %)
Worktops
ND 2/4 (50 %)
<LOQ 2/4 (50 %)
Trays
>LOQ 2/2 (100 %)
14.4–15.8 ng/cm2
Worktops
ND 4/4 (100 %)
Trays
>LOQ 2/2 (100 %)
8.3–8.5 ng/cm2
Storage cabinet (shelf and door handles) Shelfs
ND 10/10 (100 %)
Door handles
ND 2/2 (100 %)
Shelfs
ND 6/10 (60 %)
<LOQ 2/10 (20 %)
>LOQ 2/10 (20 %)
12.1–78.8 ng/cm2
Door handles
ND 2/2 (100 %)
Shelfs
ND 5/10 (50 %)
>LOQ 5/10 (50 %)
2.9–5.4 ng/cm2
Door handles
ND 2/2 (100 %)
Administration (n=27) Worktops (tables) ND 12/16 (75 %)
<LOQ 3/16 (18.8 %)
>LOQ 1/16 (6.2 %)
2.6 μg/cm2
ND 5/16 (31.3 %)
<LOQ 5/16 (31.3 %)
>LOQ 6/16 (37.4 %)
10.6–60.5 ng/cm2
ND 2/16 (12.5 %)
>LOQ 14/16 (87.5 %)
5.22–13.0 ng/cm2
Administration devices: infusion pumps ND 2/2 (100 %) ND 2/2(100 %) >LOQ 2/2 (100 %)
5.4–5.8 ng/cm2
Transfer (shelf and door handles) Shelfs
ND 7/7 (100 %)
Door handles
ND 2/2 (100 %)
Shelfs
<LOQ 1/7 (14.3 %)
>LOQ 6/7 (85.7 %)
11.8–15.2 ng/cm2
Door handles
ND 1/2
<LOQ 1/2 (50 %)
Shelfs
>LOQ 7/7(100 %)
1.5–4.1 ng/cm2
Door handles
ND 2 (100 %)
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Table 6 Surface contamination level by each drug in Hospital B (n=260)
Unit Surfaces Drug
n/n total (%)–range
CP 5FU PTX
Preparation
(n=145)
Transfer (shelf and door handles) Shelfs
ND 12/16 (75 %)
<LOQ 1/16 (6.3 %)
>LOQ 3/16 (18.2 %)
0.42–2.1 μg/cm2
Door handles
ND 12/12 (100 %)
Shelfs
ND 8/16 (50 %)
<LOQ 7/16 (43.8 %)
>LOQ 1/16 (6.2 %)
11.17 ng/cm2
Door handles
ND 4/12 (33.3 %)
<LOQ 8/12 (66.7 %)
Shelfs
ND 16/16 (100 %)
Door Handles:
ND 7/12 (58.3 %)
>LOQ 5/12 (41.7 %)
1.9–3.3 ng/cm2
Cleanroom (front barrier grille of the BSC,
chairs, worktops, trays, door handles)
BSC
ND 11/12 (91.6 %)
<LOQ 1/12 (8.4 %)
Chairs
ND 7/7 (100 %)
Worktops
ND 44/44 (100 %)
Trays
ND 5/5 (100 %)
Door handles
ND 4/6 (66.7 %)
<LOQ 2/6 (33.3 %)
BSC
ND 7/12 (58.3 %)
<LOQ 4/12 (33.3 %)
>LOQ 1/12 (8.4 %)
14.6 ng/cm2
Chairs
ND 7/7 (100 %)
Worktops
ND 34/44 (77.3 %)
<LOQ 9/44 (20.5 %)
>LOQ 1/44 (2.3 %)
20.4 ng/cm2
Trays:
<LOQ 5/5 (100 %)
Door handles
ND 3/6 (50 %)
<LOQ 3/6 (50 %)
BSC
ND 12/12 (100 %)
Chairs
ND 7/7 (100 %)
Worktops
ND 44/44 (100 %)
Trays
ND 5/5 (100 %)
Door handles
ND 4/6 (66.7 %)
>LOQ 2/6 (33.3 %)
8.96–12.4 ng/cm2
Anteroom (worktops) ND 10/10 (100 %) ND 6/10 (60 %)
<LOQ 4/10 (40 %)
ND 10/10 (100 %)
Storage cabinet (shelf and door handles) Shelfs
ND 6/6 (100 %)
Door handles
ND 6/7(85.7 %)
<LOQ 1/7 (14.3 %)
Shelfs
ND 3/6 (50 %)
<LOQ 3/6 (50 %)
Door handles
ND 6/7 (85.7 %)
<LOQ 1/7 (14.3 %)
Shelfs
ND 4/6 (66.7 %)
>LOQ 2/6 (33.3 %)
10.4–13.6 ng/cm2
Door handles
ND 7/7 (100 %)
Checking room (phone, desks and
worktops, chairs, calculators and PC)
Phone
ND 3/4 (75 %)
>LOQ 1/4 (25 %)
21.3 μg/cm2
Desks
ND 5/6 (83.3 %)
<LOQ 1/6 (16.7 %)
Chairs
ND 6/6 (100 %)
Calculators and PC
ND 2/4 (50 %)
>LOQ 2/4 (50 %)
10.0–13.4 μg/cm2
Phone
ND 1/4 (25 %)
>LOQ 3/4 (75 %)
Desks
ND 1/6 (16.7 %)
<LOQ 4/6 (66.7 %)
>LOQ 1/6 (16.6 %)
11.9 ng/cm2
Chairs
<LOQ 5/6 (83.3 %)
>LOQ 1/6 (16.7 %)
14.4 ng/cm2
Calculators and PC
ND 1/4 (25 %)
<LOQ 1/4 (25 %)
>LOQ 2/4 (50 %)
10.0–13.4 ng/cm2
Phone
ND 4/4 (100 %)
Desks
ND 6/6 (100 %)
Chairs
ND 2/6 (33.3 %)
>LOQ 4/6 (66.7 %)
2.1–6.6 ng/cm2
Calculators and PC
ND 4/4 (100 %)
Administration (n=115) Worktops (tables and cars) Tables
ND 29/41 (70.7 %)
<LOQ 9/41 (22 %)
>LOQ 3/41 (7.3 %)
3.7–20.6 μg/cm2
Cars
ND 14/21 (66.7 %)
<LOQ 4/21 (19.0 %)
>LOQ 3/21 (14.3 %)
0.4–2.1 μg/cm2
Tables
ND 34/41 (83 %)
<LOQ 6/41 (14.6 %)
>LOQ 1/41 (2.4 %)
12.0 ng/cm2
Cars
ND 11/21(52.4 %)
<LOQ 6/21 (28.6 %)
>LOQ 4/21 (19.0 %)
12.4–33.9 ng/cm2
Tables
ND 18/41 (43.9 %)
>LOQ 23/41(56.1 %)
1.3–260.9 ng/cm2
Cars
ND 6/21 (28.6 %)
>LOQ 15/21 (71.4 %)
0.7–479.7 ng/cm2
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(37.2 and 18.3 %, respectively). PTX-contaminated
samples (9 and 50.4 %) were found in preparation and
administration areas. The highest measured value for CP
(21.3 μg/cm2) was obtained on the phone of the
checking room that gives direct support to the
cleanroom from the preparation unit. In the case of
5FU, the highest value (41.3 ng/cm2) was found in one
control panel infusion pump in the administration unit.
The surface that obtained the highest measured value of
PTX (1,131.4 ng/cm2) was also in a infusion pump.
Discussion
Antineoplastic drugs play an important role in cancer
treatment, however not without side effects linked to
their carcinogenic, mutagenic, and teratogenic proper-
ties. These side effects represent a potential health risk
for workers handling these drugs during preparation or
administration procedures. Moreover, carcinogenic,
mutagenic, and teratogenic effects usually do not de-
pend on a minimum dose but instead on a prolonged
exposure. Therefore, it can be concluded that there is no
safety threshold dose concerning exposure to these
drugs. It would be appropriate to apply the ALARA
principle: keep exposure/contamination levels as low
as reasonably achievable (Hon et al. 2013).
Although several antineoplastic drugs are commonly
employed in these hospital settings, to assess exposure,
we used three antineoplastic drugs, CP, 5FU, and PTX,
as surrogate markers for exposure. This can be regarded
as a limitation as it assumes that similar levels of con-
tamination can be present for the other agents. Those
drugs are among the most frequently employed, and in
high amounts, every day in both hospitals. Most of the
studies published concerning this issue used the same
approach (Larson et al. 2003; Mason et al. 2005;
Castiglia et al. 2008; Hedmer et al. 2005, 2008; Touzin
et al. 2009; Kopp et al. 2013). Additionally, these drugs
are also recommended as markers for chemical contam-
ination monitoring by ISOPP (2007). Additionally,
since the same aseptic techniques are employed in the
preparation of admixtures containing these or other
drugs, similar results are to be expected.
The sampling strategy followed is another potential
limitation of our study as contaminated surfaces could
have been overlooked. However, since the observations
were performed on different days and the drug flow was
well described, we believe that it was possible to iden-
tify the potentially contaminated surfaces and the ones
Table 6 (continued)
Unit Surfaces Drug
n/n total (%)–range
CP 5FU PTX
Administration devices: Control
panels and Infusion pumps
ND 22/25 (88 %)
<LOQ 3/25 (12 %)
ND 12/25 (48 %)
<LOQ 8/25 (32 %)
LOQ 5/25 (20 %)
10.7–41.3 ng/cm2
ND 16/25 (64 %)
>LOQ 9/25 (36 %)
1.2–1131.4 ng/cm2
Treatment chairs (armrests) and beds Treatment chairs
ND 6/9 (66.7 %)
<LOQ 1/9 (11.1 %)
>LOQ 2/9 (22.2 %)
0.3–1.1 μg/cm2
Beds
ND 2/2 (100 %)
Treatment chairs
ND 9/9 (100 %)
Beds
ND 2/2 (100 %)
Treatment chairs
ND 9/9 (100 %)
Beds
ND 2/2 (100 %)
Personal Protection Equipment (gloves) ND 8/10 (80 %)
< LOQ 2/10 (20 %)
ND 9/10 (90 %)
>LOQ 1/10 (10 %)
11.4 ng/cm2
ND 5/10 (50 %)
>LOQ 5/10 (50 %)
14.7–414.7 ng/cm2
Drug container (packing after preparation
and box for manual transportation)
Packing
ND 5/5(100 %)
Box
ND 2/2(100 %)
Packing
ND 3/5(60 %)
<LOQ 1/5 (20 %)
>LOQ 1/5 (20 %)
13.7 ng/cm2
Box
ND 1/2 (50 %)
>LOQ 1/2 (50 %)
14.6 ng/cm2
Packing
>LOQ 5/5 (100 %)
34.8–46.7 ng/cm2
Box
ND 1/2 (50 %)
>LOQ 1/2 (50 %)
6.3 ng/cm2
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that represent higher risk for workers due to the fact that
they are frequently handled. Furthermore, we studied
only surfaces that may be touched/handled by the
workers and avoided surfaces such as floors of the
preparation and administration units, accordingly to
other studies (Schmaus et al. 2002; Hedmer et al.
2008; Castiglia et al. 2008; Kopp et al. 2013; Hon
et al. 2013).
This type of information is very useful because it
allows the identification of the “weak points” in the
working and cleaning procedures and where
preventive actions can have the best result regarding
minimizing workplace contamination. Regarding this
aspect, Touzin et al. (2009) mentioned that environmen-
tal monitoring can have an important role for protecting
workers from exposure to chemical agents because it
can identify surfaces with high risk and to assess if the
control measures, such as surfaces cleaning, had the
expected results.
In both hospitals, the administration unit obtained
higher values for the three surrogate markers with
the exception of 5FU in hospital B. These results are
corroborated by Hedmer and colleagues (2008) and
Fransman and colleagues (2004) that concluded that
dermal exposure is common among oncology
nurses. Contrary to our findings, Hon et al. (2013)
suggested the drug preparation stage as the most
probable to be contaminated due to the concentrated
drugs that are routinely handled and mixed.
However, our results can be explained by the fact
that preparation units in Portugal implement a higher
number of safety procedures, since this is a much
regulated area audited frequently by Portuguese
Authority of Medicines and Health Products.
Another concurring factor was referred by Touzin
et al. (2009): different job description and less train-
ing from the workers can also contribute to high
levels of contamination.
Our results showed contamination by drugs on days
when those analytes were not used at all in preparation
and administration. The same kind of results was found
in a study developed by Castiglia et al. (2008). These
results probably are resulting from defective cleaning
procedures that can be related with the detergents used
and/or the frequency of the cleaning procedures and,
also, the surfaces that are object of the cleaning actions.
Similar results led other authors to the same type of
conclusions (Hedmer et al. 2008; Touzin et al. 2010;
Turci et al. 2011; Hon et al. 2013).
Moreover, our results showed different results in the
number of surfaces with contamination between the
drugs considered. In detail, it was possible to observe
less CP-contaminated surfaces (4.6 %) than 5FU and
PTX (10.7 and 26.9 %, respectively) (Table 4). This can
be explained by the lower sensitivity of the CP method,
leading to the incapacity to measure values below
30 μg, than in the cases of 5FU (LOQ=1,000 ng) and
PTX (LOQ=50 ng). Additionally, CP is unstable at
room temperature (Hedmer et al. 2004). In an opposite
way, PTX presented higher number of contaminated
surfaces (21.7 %) when comparing with the other two
drugs studied (4.6 % for CP and 10.7 % for 5FU)
(Table 4). This result can be due to two different factors
that characterize PTX: low aqueous solubility and high
chemical stability. These two factors combined can ex-
plain the results because probably this drug is more
persistent in the surfaces, resisting more easily to envi-
ronment conditions and cleaning procedures (Yang et al.
2007).
Regarding hospital A, surfaces contaminated with all
surrogate markers were found in both preparation and
administration areas, although contamination was sig-
nificantly higher in the administration area. In the prep-
aration area, we found contamination in the refrigerator
closet handle where drugs are stored with the primary
packaging. As demonstrated in other studies (Delporte
et al. 1999; Nygren et al. 2002; Favier et al. 2003;
Mason et al. 2003; Hedmer et al. 2005; Connor et al.
2005; Touzin et al. 2009; Turci et al. 2011), probably,
the package is the main source of contamination.
Moreover, the handling of these primary packaging is
done some times without protection gloves by the phar-
macists and, before that, by the workers in the hospital
storage unit. This raises concern related with the poten-
tial of other hospital areas to be contaminated with
antineoplastic drugs and, consequently, an increase in
number of workers being potentially exposed (Hon et al.
2011).
The highest contamination of PTX in hospital was
determined on the transfer. The transfer is commonly
sampled in other studies (Schierl et al. 2009; Connor
et al. 2010; Hon et al. 2013) due to the high handling
frequency of this equipment by the workers that prepare
and administer the cytotoxic drugs. Here, we have to
consider that probably contaminated worker’s gloves
and metal trays are responsible for the transfer contam-
ination. This demonstrates that contamination can
spread throughout both services. Widespread
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contamination was also observed in other studies, de-
spite the implementation of safety procedures for han-
dling antineoplastic drugs (Schmaus et al. 2002;
Castiglia et al. 2008; Connor et al. 2010). Furthermore,
and considering that the metal trays are used to transport
drugs after preparation, a study developed by Hon and
colleagues (2011) showed that the trays are the most
frequently contacted surface in the medication circuit.
Curiously, and regarding the trays contamination, Kopp
et al. (2013) demonstrated that there were significantly
lower levels of surfaces contamination when prepara-
tions, after use, were transported on a tray instead of per
hand (Kopp et al. 2013). Probably, in the present re-
search, the most important factor that is influencing
surfaces contamination is the inadequate frequency of
glove changing by workers.
Considering hospital B, as in hospital A, contamina-
tion was found for all surrogate markers in both prepa-
ration and administration areas. Nevertheless, in the
administration units, we observed higher contamination
level.
In detail, it is important to mention that the highest
surface contamination results were obtained in samples
from hospital B. The result of the phone from the
checking room is particularly problematic since in this
place there is no direct handling of cytotoxic drugs as
they were already prepared in the cleanroom. Moreover,
the phone is frequently used without gloves since it is on
a desk where normally the registration of the drug
prepared takes place. In fact, it is used by all the person-
nel that work in the checking room. In this case, the
inappropriate surfaces cleaning together with the incor-
rect working procedures surely contributed for the con-
tamination found. The same kind of results were ob-
served in a study developed in Italian hospitals
(Castiglia et al. 2008) that concluded that the cause of
contamination of this type of surfaces (phones, chairs,
closets, and others not directly related with drug prepa-
ration) were the workers gloves that were not removed
immediately after drug handling. As in our study, other
studies (Minoia et al. 1998; Mason et al. 2005;
Fransman et al. 2004, 2007) found contamination on
the worker’s gloves. For instance, the gloves that was
possible to sample in the administration unit of hospital
B, showed contamination by 5FU (11.4 ng/cm2) and,
also, high amounts of PTX (414.7 ng/cm2).
The higher results for 5FU and PTX in hospital B were
found on equipment from the administration unit, namely
in administration devices such as infusion pumps.
Once again, these results may be due to spillage
during the administration process as well as to inade-
quate cleaning protocols or incorrect working proce-
dures (Sessink et al. 1992; Acampora et al. 2005;
Touzin et al. 2009; Turci et al. 2011; Hon et al. 2013).
In a recent study, Kopp et al. (2013) observed consider-
able amounts of 5FU on infusion pumps and considered
high risk of exposure linked to the fact that this device
was sometimes handled without gloves. The same type
of results was published earlier by Fransman and
colleagues in 2007. Additionally, a study developed by
Hon and colleagues (2011) stated that these infusion
pumps was the most contacted object by workers during
drug administration.
Our results showed also that some surfaces (8.6 %)
were contaminated with more than one antineoplastic
drugs. Additionally, most of these samples were from
the administration units. Our results can be explained
once again by the fact that there are more strict safety
and hygiene rules in preparation units when compared
with administration units as demonstrated by the high
number of organizations that research on this field de-
veloping constantly new rules and safety measures
(ISOPP 2007; NIOSH among others).
This raises attention to another important aspect that
should be considered for the risk assessment process: in
this setting, exposure is characterized by being simulta-
neous to different antineoplastic drugs and the health
effects of such mixtures are unpredictable (Fucic et al.
1998; Cavallo et al. 2005; Kopjar et al. 2009).
Although the discussion of data was based on the
results obtained in the samples that revealed levels of
contamination possible to quantify (>LOQ), we cannot
forget that was also found a significant number of sam-
ples that was possible to detect one or more drug
(35.8 %) (<LOQ) (Tables 5 and 6). This data is also
relevant, considering that the risk associate to these
drugs are more related with the exposure than with a
dose, due to fact that the health effects related can be
observe (even with lower probability) with only one
contact or moment of exposure. Moreover, when
performing statistical analysis of this data, administra-
tion units also presented the worst results, supporting the
previous results and comments.
In view of the results obtained, some recommenda-
tions must be pointed out, namely the following: change
the gloves more often, the trays must be used for only
one admixture and then cleaned and the worktops and
administration devices must be cleaned more frequently.
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As recommended by Hedmer et al. (2005a), we con-
sider relevant to study in more detail how the levels of
surface contamination varies over time in workplaces
that handle antineoplastic drugs. The obtained data in
this research only permits to consider these workplaces
as contaminated environments and all the safety precau-
tions must be applied.
Conclusions
Our results show that there is a real risk of exposure in
the preparation and administration units of the studied
hospitals due to the contamination found in many dif-
ferent and frequently touched surfaces.
The obtained results revealed that administration
areas of both hospitals have higher levels of contami-
nated surfaces than preparation areas. Factors contribut-
ing to this are related with different work practices and
different levels of awareness to the exposure problem.
Additionally, the results point out to poor cleaning prac-
tices and/or incorrect working procedures.
Considering the findings, specific measures should
be taken in both hospitals, namely the following: review
the cleaning protocols (surfaces to clean, cleaning prod-
ucts and cleaning frequency); constantly promote good
practices and safety procedures among all the profes-
sionals that handle antineoplastic drugs such as remove
gloves immediately after drug handling and always
before touching any surface; and implement routine
monitoring of surfaces contamination in order to guar-
antee the appliance of safety measures and procedures.
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